Published on 4 Apr 2024 on Zacks via Yahoo Finance
Simulations Plus SLP reported second-quarter fiscal 2024 earnings of 20 cents per share, unchanged on a year-over-year basis. The figure topped the Zacks Consensus Estimate by 11.1%.The top line increased 16% year over year to $18.3 million driven by higher software revenues in the Clinical Pharmacology & Pharmacometrics (CPP) and Cheminformatics business units. The top line beat the Zacks Consensus Estimate by 7.2%.
Following the results, shares of SLP are up 9.1% in the premarket trading on Apr 4.
Simulations Plus, Inc. Price, Consensus and EPS Surprise